CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 757,585 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05321433
NCT05321433N/ACompleted
CompareCT.gov

The Association Between Tobacco Use and COVID-19 Infection and Adverse Outcomes in Three Nordic Countries: a Pooled Analysis

Karolinska Institutet·observational·Posted Apr 11, 2022·Updated Mar 6, 2024

In Brief

An observational study for COVID-19 and 6 related conditions. Completed, enrolled 757,585 participants across 1 site.

Detailed Summary

This is an observational study of pooled population-based samples in three Nordic countries. Country-specific data has already been analysed in previous studies in Sweden, Finland, and Norway. The primary objective is to examine the association between tobacco use, the risk of SARS-CoV-2 infection, and adverse Outcomes using pooled population-based samples.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19, Respiratory Tract Infections, Infections, Pneumonia, Viral, Pneumonia, Virus Diseases, SARS-CoV-2 Infection
CountriesSweden
CollaboratorsFinnish Institute for Health and Welfare, Norwegian Institute of Public Health

Timeline

N/ACompletedFinished
2023202420252026
First PostedApr 11, 2022
Enrollment StartApr 1, 2022
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.2 years ago